SRI 37892

For research use only. Not for therapeutic Use.

  • CAT Number: I036635
  • CAS Number: 1030769-75-5
  • Molecular Formula: C26H19N5O2S
  • Molecular Weight: 465.53
  • Purity: ≥95%
Inquiry Now

SRI 37892(CAT: I036635) is a small-molecule inhibitor targeting Frizzled protein 7 (Fzd7), a key receptor in the Wnt signaling pathway. With an IC50 of 2 μM, SRI 37892 effectively inhibits cancer cell proliferation by blocking Wnt/Fzd7-mediated signaling. This disruption of Wnt signaling, which is often dysregulated in various cancers, positions SRI 37892 as a valuable tool in cancer biology research. It is particularly useful for investigating the role of Fzd7 in tumor progression and for the development of targeted anticancer therapies. SRI 37892 is suitable for in vitro and preclinical studies focused on Wnt pathway modulation.


CAS Number 1030769-75-5
Synonyms

4-(benzimidazol-1-yl)-N-[4-(2-oxo-3,4-dihydro-1H-quinolin-6-yl)-1,3-thiazol-2-yl]benzamide

Molecular Formula C26H19N5O2S
Purity ≥95%
IUPAC Name 4-(benzimidazol-1-yl)-N-[4-(2-oxo-3,4-dihydro-1H-quinolin-6-yl)-1,3-thiazol-2-yl]benzamide
InChI InChI=1S/C26H19N5O2S/c32-24-12-8-17-13-18(7-11-20(17)28-24)22-14-34-26(29-22)30-25(33)16-5-9-19(10-6-16)31-15-27-21-3-1-2-4-23(21)31/h1-7,9-11,13-15H,8,12H2,(H,28,32)(H,29,30,33)
InChIKey DXSMYUKZPWJQFM-UHFFFAOYSA-N
SMILES C1CC(=O)NC2=C1C=C(C=C2)C3=CSC(=N3)NC(=O)C4=CC=C(C=C4)N5C=NC6=CC=CC=C65
Chemistry Calculators Dilution Calculator
In vivo Formulation Calculator
Molarity Calculator
Molecular Weight Calculator
Reconstitution Calculator

Request a Quote